OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis
Jiaxi Liu, Peng Wang, Liqi Shang, et al.
Hepatology International (2023) Vol. 18, Iss. 2, pp. 595-609
Closed Access | Times Cited: 14
Jiaxi Liu, Peng Wang, Liqi Shang, et al.
Hepatology International (2023) Vol. 18, Iss. 2, pp. 595-609
Closed Access | Times Cited: 14
Showing 14 citing articles:
The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors
Xiaoyu Huang, Gang Peng, Yaqing Kong, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 203-217
Open Access
Xiaoyu Huang, Gang Peng, Yaqing Kong, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 203-217
Open Access
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study
Xiaokun Chen, Xiangan Wu, Peng Wei, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 561-577
Open Access
Xiaokun Chen, Xiangan Wu, Peng Wei, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 561-577
Open Access
PD-1 inhibitors improve the efficacy of tyrosine kinase inhibitors combined with transcatheter arterial chemoembolization in advanced hepatocellular carcinoma: a meta-analysis and trial sequential analysis
Jiahui Yu, Yong Li, Yuting Yang, et al.
Scandinavian Journal of Gastroenterology (2025), pp. 1-13
Closed Access
Jiahui Yu, Yong Li, Yuting Yang, et al.
Scandinavian Journal of Gastroenterology (2025), pp. 1-13
Closed Access
Breaking bottlenecks: the future of hepatocellular carcinoma clinical trials and therapeutic targets
Weixiong Zhu, Chuanlei Fan, Yongqing Zhao, et al.
Hepatology International (2025)
Closed Access
Weixiong Zhu, Chuanlei Fan, Yongqing Zhao, et al.
Hepatology International (2025)
Closed Access
Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: a systematic review and meta-analysis
Hengyu Tian, Chidan Wan
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Hengyu Tian, Chidan Wan
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Machine learning for prognostic impact in elderly unresectable hepatocellular carcinoma undergoing radiotherapy
Yuxin Shi, Xian‐Guo Liu
Frontiers in Oncology (2025) Vol. 15
Open Access
Yuxin Shi, Xian‐Guo Liu
Frontiers in Oncology (2025) Vol. 15
Open Access
Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis
YiFeng Liang, L M Gan, DeJin Zeng, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2652-2664
Closed Access | Times Cited: 3
YiFeng Liang, L M Gan, DeJin Zeng, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2652-2664
Closed Access | Times Cited: 3
Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma
Nojan Bajestani, Junjie Gavin Wu, Ahmed E. Hussein, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1432-1432
Open Access | Times Cited: 2
Nojan Bajestani, Junjie Gavin Wu, Ahmed E. Hussein, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1432-1432
Open Access | Times Cited: 2
Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis
Huipeng Fang, Qiao Ke, Shiji Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Huipeng Fang, Qiao Ke, Shiji Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Systemic Treatment in Intermediate Stage (Barcelona Clinic Liver Cancer-B) Hepatocellular Carcinoma
Dimitrios S. Karagiannakis
Cancers (2023) Vol. 16, Iss. 1, pp. 51-51
Open Access | Times Cited: 4
Dimitrios S. Karagiannakis
Cancers (2023) Vol. 16, Iss. 1, pp. 51-51
Open Access | Times Cited: 4
Efficacy and safety of TACE combined with tyrosine kinase inhibitors and camrelizumab for unresectable hepatocellular carcinoma: A systematic review and meta‑analysis
Jiahui Yu, Yan Duan, Wei Song, et al.
Oncology Letters (2024) Vol. 28, Iss. 2
Open Access | Times Cited: 1
Jiahui Yu, Yan Duan, Wei Song, et al.
Oncology Letters (2024) Vol. 28, Iss. 2
Open Access | Times Cited: 1
Efficacy and Safety of Transarterial Chemoembolization Plus Lenvatinib with or Without Tislelizumab as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Jiayun Jiang, Hui Zhang, Jiejuan Lai, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1607-1622
Open Access | Times Cited: 1
Jiayun Jiang, Hui Zhang, Jiejuan Lai, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1607-1622
Open Access | Times Cited: 1
Prognostic Prediction and Risk Stratification of Transarterial Chemoembolization Combined with Targeted Therapy and Immunotherapy for Unresectable Hepatocellular Carcinoma: A Dual-Center Study
Wendi Kang, Huafei Zhao, Qinshu Lian, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 2169-2179
Open Access | Times Cited: 1
Wendi Kang, Huafei Zhao, Qinshu Lian, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 2169-2179
Open Access | Times Cited: 1
Comprehensive Bioinformatics Analysis and Machine Learning of TTK as a Transhepatic Arterial Chemoembolization Resistance Target in Hepatocellular Carcinoma
Yangyang Xiao, Youwen Hu
Molecular Biotechnology (2024)
Closed Access
Yangyang Xiao, Youwen Hu
Molecular Biotechnology (2024)
Closed Access
